drug induced nephritis
DESCRIPTION
How a common Cold may progress to Kidney Failure.TRANSCRIPT
![Page 1: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/1.jpg)
Acute Renal Failure and Drug-Induced Nephrotoxicity
Case Presentation
Joseph O. Oweta Intern Pharmacist ( MNRRH)Karen Ng, BScPharm, ACPR, UBC PharmD Candidate
April 4, 2013
![Page 2: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/2.jpg)
Case: NJ
• ID: NJ, 12 yo female; ~40 kg• PC: Fever, hematuria, facial swelling x 2 wks (worse
in morning)• HPI: – Unwell since 3 wks ago, high grade persistent fever– Taken to clinic, diagnosed with malaria– Self referral to Naguru hospital after vomiting 6-7x/d– At Naguru hospital, treated for bronchopneumonia and
malaria frequency of vomiting reduced– Decreased urine output
![Page 3: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/3.jpg)
Case: NJ
• NKDA• Meds PTA: – Ceftriaxone 1 g IV x 2– Gentamicin 2 doses– Hydrocortisone – Cefixime– Atemisinin/lumefantrines– Salbutamol– Paracetamol
![Page 4: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/4.jpg)
Case: NJ
• PMHx:– SVD– Birth weight ¬5 kg; delivered in clinic– Breastfed for 5 months then started on soft feeds.
Has been feeding well– Immunizations UTD– Normal growth and development– P3 pupil, last born of 6 children, elder siblings alive
and well
![Page 5: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/5.jpg)
Case: Physical ExamVitals T 35.8oC, HR 88, BP 110/75, RR 35
HEENT Facial swelling since 2 weeks ago; severe in the morning, reduces throughout day
CNS Fully conscious, no focal neurological deficits
CVS S1, S2 normal; no added sounds
Resp No distress, bronchovesicular breath sounds
GI Soft, liver 3 cm below costal margin, no splenomegaly, no renal angle tendernessLower abdo pain: severe, persistentPoor appetite, no diarrhea, previous vomiting
GU Hematuria, ?reduced urine output, normal frequency (5x/day), no dysuria
![Page 6: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/6.jpg)
Case: Labs (Mar 20, 2013)
• CBC: WBC 9.97 Neut 6.57, Hgb 5.8 g/dL, Plt 624– RBC 2.29, HCT 17.3%, MCV 75.5 fL, MCH 25.3 pg, MCHC 33.5 g/dL,
RDW-CV 16.4%– Severe anemia, thrombocytosis
• Liver: Alb 36.6, ALT 5.3, AST 21.5, Bili: 2.3, GGT: 26.8, Total protein 74.3
• Amylase: 69.9• Renal: SCr 1711 umol/L, Cl: 89.8, K: 7.57, Na: 127.5, BUN: 51.2
mmol/L• ASO ver. 2 (specific proteins) : 279.30 IU/mL (ref: 0.00-200.00)
– Mar 25• No MPS
![Page 7: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/7.jpg)
Case: Laboratory SummaryMar 20, 2013 Mar 25, 2013
CRE 1711 394
Na 127.5 133
K 7.57 4.07
Hb 5.8 8.2
![Page 8: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/8.jpg)
Case: diagnostics
• Abdo U/S (Mar 19, 2013)– Kidneys: increased echogenicity with scarring of renal
cortex– Bladder normal– Uterus normal– Liver/spleen normal– Bowel loops normal– U/S scan findings suggestive of renal parenchymal disease
• Urinalysis– Normal colour
![Page 9: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/9.jpg)
Case: Diagnosis
• Diagnosis: – Acute glomerular nephritis– R/O nephrotic syndrome– Severe anaemia secondary to haematuria?– UTI??
![Page 10: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/10.jpg)
Case: Treatment
• Admit to acute care unit• Transfused x 1• Abx– Ceftriaxone 1 g IV q24h (Mar 20- 25)– Prednisolone 10 mg po bid x 1 wk (Mar 20-26) – Ampicillin 500 mg IV q6h (Mar 25-
• Paracetamol 500 mg po tds x 3d) • Folic acid 10 mg po daily x 1 month• Multivitamins 10 mg po daily x 1 wk
![Page 11: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/11.jpg)
Case: NJ
Summary:7 yo female with 3 weeks hx of vomiting 2 wks of body swelling starting with facial swelling that resolves with increasing hours of day, 10 days lower abdo pain with hematuria, presenting with acute renal injury
![Page 12: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/12.jpg)
Case:Questions to Consider
• What is the etiology of NJ’s acute renal failure? What are possible drug causes?
• How should NJ’s acute renal failure be managed?
• Considering possible drug causes, which are the most likely in NJ’s case?
![Page 13: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/13.jpg)
Objectives
1. Define acute kidney injury (AKI).2. Understand the stages of AKI based on RIFLE classification
systems.3. Be familiar with the three pathophysiological categories of
AKI and some of the etiologies behind the three major categories.
4. State the 3 types of intrinsic acute renal failure and the related drug causes
5. Describe the mechanisms of drug-induced nephrotoxicities specifically relating to acute renal failure
6. Identify patients at risk for renal injury and strategies for prevention.
![Page 14: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/14.jpg)
Acute Kidney Injury (AKI)
• Abrupt and sustained decrease in renal function resulting in retention of nitrogenous (urea and creatinine) and non-nitrogenous waste products
![Page 15: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/15.jpg)
The Kidney is Vulnerable
• Responsible for excretion of many drugs• Routinely exposed to high concentrations of
drugs and metabolites• Nephrotoxins can accumulate– Kidney is highly vascular– Reabsorption of glomerular filtrate increases
intraluminal nephrotoxin concentrations
![Page 16: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/16.jpg)
KDIGO Definition of AKI
KDIGO = Kidney Disease: Improving Global Outcomes
• An increase in serum creatinine of ≥ 0.3 mg/dL ≥26.5 μmol/L (0.3 mg/dL ) within 48 hours
• An increase in serum creation of ≥1.5 times baseline, which is known or presumed to have occurred within the prior 7 days
• Urine volume <0.5 mL/kg per hour x > 6 hours
Kidney Int Suppl 2012; 2:8
![Page 17: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/17.jpg)
RIFLE Classification of AKI Severity
![Page 18: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/18.jpg)
Can you classify NJ’s AKI based on RIFLE staging systems? What
information do you need?
• Missing information:– Urine output– Serial/repeat SCr
![Page 19: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/19.jpg)
What are the four drug-related renal syndromes?
• Drugs can cause four major renal syndromes:1. Acute renal failure2. Nephrotic syndrome3. Renal tubular dysfunction with renal potassium
wasting and acidosis4. Chronic renal failure
![Page 20: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/20.jpg)
Etiology of Acute Renal Failure
• Pre-renal causes• Intrinsic causes• Post-renal causes
![Page 21: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/21.jpg)
Etiology of Acute Renal FailurePre-renal •Underperfusion of otherwise normal kidney
•Quickly reversible with appropriate therapy•Continued renal hypoperfusion can progress to intrinsic renal failure
Intrinsic •Disease of the renal parenchyma•Most often caused by renal hypoperfusion or ischemia, endogenous and exogenous nephrotoxic substances
Post-renal •Obstructions within urinary tract (e.g. blood clots, stones)•Extrinsic obstructions (e.g. tumors, retroperitoneal fibrosis)
![Page 22: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/22.jpg)
![Page 23: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/23.jpg)
http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/nephrology/acute-kidney-injury/
![Page 24: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/24.jpg)
Evaluation of Etiology of AKI• Findings that suggest prerenal causes:
– Volume depletion or shock states– Congestive heart failure– Severe liver disease or other edematous states
• Findings that suggest intrinsic renal disease– Exposure to nephrotoxic drugs or hypotension– Recent radiographic procedures with contrast
• Findings that suggest postrenal causes– Palpable bladder or hydronephrotic kidneys– Enlarged prostate– Abnormal pelvic examination– Large residual bladder urine volume– History of renal calculi
![Page 25: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/25.jpg)
Evaluation of AKIPatients at Risk
Pre-renal AKI •Patients with compromised renal blood flow• Bilateral renal artery stenosis
•Patients with decreased effective circulatory volume• Cirrhosis• Nephrotic syndrome• Heart failure
Intrinsic AKI •Exposure to nephrotoxic drugs (see intrinsic AKI slides)Post-renal AKI
•Severe volume depletion•Underlying renal insufficiency•Bolus drug administration•Metabolic disorders (e.g. metabolic acidosis or alkalosis)
![Page 26: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/26.jpg)
Drug Causes of AKIPre-renal AKI •Drugs may reduce volume or pressure or both of
blood delivered to kidney•Diuretics, radiocontrast media, cyclosporine, tacrolimus, NSAIDs, interleukin-2, ACEI
Intrinsic AKI •(see intrinsic AKI slides)
Post-renal AKI
•Crystal formation: acyclovir, sulfonamides, methotrexate, indinavir, triamterene, vitamin C in large doses
![Page 27: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/27.jpg)
Urinary Findings of AKIPre-renal AKI •Low urine volume and sodium excretion
•High osmolality•Urine sediment usually without casts, RBC, WBC, protein
Intrinsic AKI •(see intrinsic AKI slides)
Post-renal AKI
•Urine sediment may contain RBC, WBC, crystals
![Page 28: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/28.jpg)
What are the possible causes of NJ’s AKI?
• Prerenal: decreased fluid intake?• Intrinsic:– Allergic reaction to antibiotic– Nephrotoxic antibiotics
• Postrenal: ultrasound did not demonstrate obstruction
![Page 29: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/29.jpg)
Prerenal/ Volume Responsive AKI
• Etiology:– Renal losses– GI losses– Fluid sequestration, inadequate perfusion pressures
• Capillary leak (sepsis)• Hypoalbuminemic states
– CHF– Cirrhosis, splanchnic vasodilation, hypoalbuminemia
– Impaired renal autoregulation• ACEI/ARBs• Contrast, calcineurin inhibitor, ampho B, vasopressors (osmotic
vasoconstriction off AA)• NSAIDs• Vascular disease exacerbation
![Page 30: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/30.jpg)
Prerenal/ Volume Responsive AKI
• Diagnostics– Pre-renal urine biochemistry• Hyaline casts or granular casts, bland sediment• Increased osmolality > 500• Decreased sodium• Decreased fractional excretion of sodium, urea, uric
acid, lithium• SCr:BUN < 12.4 signals pre-renal
![Page 31: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/31.jpg)
What are the 3 types of intrinsic ARF?
1. Acute tubular necrosis (ATN)2. Acute intrinsic nephritis (AIN)3. Thrombotic microangiopathy
![Page 32: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/32.jpg)
Differentiation Between ATN and AIN
![Page 33: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/33.jpg)
Intrinsic AKIMechanisms of Injury
Acute Tubular Necrosis
•Direct tubular toxicity•Deranged cellular energy production•Free radical injury•Heme tubular toxicity•Abnormal phospholipid metabolism•Intracellular calcium toxicity•Usual sites of injury: early or late segments of proximal tubule
Acute Allergic Interstitial Nephritis
![Page 34: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/34.jpg)
Acute Tubular Necrosis
Aminoglycosides ATN– Gradual increase SCr after 5-10 days– Tubular epithelial cell damage leading to obstruction of
tubular lumen– Non-oliguria >500 mL/day; granular casts in urine– Risk factors:
• Combination with other nephrotoxic drugs• Total cumulative dose; trough levels >2 mg/L• Repeated courses of A/G • Prolonged therapy >10 days• Dehydration
– Management: reversible if D/C drug, adequate hydration, monitor levels
![Page 35: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/35.jpg)
Acute Tubular Necrosis
Ampho B ATN– Direct tubular epithelial cell damage; binds to cell wall
resulting in increased tubular permeability and necrosis– Increased SCr, BUN, decreased Mg, K (urine wasting)-
monitor q1-2d – Distal RTA, polyuria (nephrogenic DI)– Risk factors:
• Combo with other nephrotoxic drugs• Total cumulative dose; daily dose > 0.5 mg/kg/day• Dehydration
– Management: reversible if D/C drug, hydration (1L NS daily)– All lipid-based preps decrease occurrence of nephrotoxicity
![Page 36: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/36.jpg)
Acute Tubular Necrosis
Radiographic Contrast Media ATN– Onset within 12-24 hr, SCr peaks 2-5 days after
exposure, recovery usually after 4-10 d– Direct tubular necrosis, renal ischemia– Typically non-oliguric– Urinalysis: hyaline and granular casts, low FENa– Risk factors: DM, CKD, prestudy dehydration– Management: low-osmolality nonionic contrast
agents, smallest dose, hydration
![Page 37: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/37.jpg)
Acute Allergic Interstitial Nephritis
• Clinical presentation:– Systemic manifestations of hypersensitivity
reaction (e.g. fever, rash, arthralgias)– Onset after drug exposure:• 1st exposure: as long as several weeks• 2nd exposure: 3-5 days• As short as 1 day after rifampin• As long as 18 months with NSAIDS
![Page 38: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/38.jpg)
Acute Allergic Interstitial NephritisImplicated Drugs:
• Penicillins• Cephalosporins• Cocaine• Sulfonamides• NSAIDs • Diuretics• Lithium• Phenytoin• Valproic acid
• Amphotericin B• Streptokinase• 5-aminosalicylates• Allopurinol• Rifampin• Some Chinese herbs
![Page 39: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/39.jpg)
Acute Allergic Interstitial Nephritis
• Urinary Findings:– Urinalysis:
• WBC, RBC, white cell casts• Fractional excretion of sodium often >1%• Protein excretion usually mild• Eosinophilia or eosinophiluria present >75% of cases
• Diagnosis:– Diagnosis confirmed only by kidney biopsy– Biopsy indicated only if renal failure progresses or
persists despite stopping the offending drug
![Page 40: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/40.jpg)
Acute Allergic Interstitial NephritisTreatment
• Stop the offending drug• Steroid therapy if renal failure persists– Prednisone 1-2 mg/kg/day PO x 4-6 weeks
• Cyclophosphamide if recovery not seen after trial of prednisone
![Page 41: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/41.jpg)
Thrombotic Microangiography
• Clinical presentation:– Fever, hemolytic anemia, thrombocytopenia, renal
dysfunction, CNS abnormalities, TTP– Pathologic hallmark: hyaline thrombi in microvasculature of
many organs• Changes in kidney:
– Afferent arterioles– Glomerular thrombosis– Thickening of glomerular capillary wall
• Drugs implicated:– Cyclosporin, tacrolimus, chemotherapeutic agents, ticlopidine,
clopidogrel, estrogen-containing contraceptives, quinine, cocaine
![Page 42: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/42.jpg)
Post-Renal Nephropathy
• Rhabdomyolysis– Intratubular precipitation of myoglobulin– Prevention: hold statin while on clarithro/erythro or itraconazole
• Drug-induced crystalluria– Drug insoluble in urine crystallizes in distal tubule– Risk factors:
• Decreased circulating volume• Renal dysfunction• Acid or alkaline urine pH
– Prevention:• Dose adjustment for renal failure• Volume expansion to enhance urinary output• Urinary alkalinization (for weak acids)
![Page 43: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/43.jpg)
Post-Renal Nepropathy
• Implicated Drugs:• Methotrexate
– Weak acid- precipitates in acidic urine (pH < 7)– Precipitation of MTX and its metabolites in renal tubules– High dose MTX (12-15 g/m2)– Prevention:
» Diuresis- U/O 100-200 mL/h x 24h post-high dose MTX» Urinary alkalinization (sodium bicarb 25-59 mEq/L
hydration fluid)
![Page 44: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/44.jpg)
Post-Renal Nepropathy
• Implicated Drugs:• Acyclovir
– Weak acid and weak base– Intratubular precipitation of acyclovir in dehydrated oliguric
patients– Needle-shaped crystals– Risks/Prevention
» IV- too fast infusion rate- infuse over 1 h» High dose > 500 mg/m2
» Dehydration- IV NS» Pre-existing renal failure- adjust dose» Other nephrotoxins
![Page 45: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/45.jpg)
Post-Renal Nepropathy
• Implicated Drugs:• Indinavir
– Weak base- precipitates in alkaline urine– Crystal nephropathy, dysuria, urinary freq, rectangular cystals– Risk/Prevention:
» Severe volume depletion» Recipitation prevented by consumption of ~2L fluid/d
![Page 46: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/46.jpg)
Post-Renal Nepropathy
• Implicated Drugs:• Sulphonamides
– Weak acid- precipitates in acidic urine– Higher doses– More common with sulfadiazine– Risk/prevention:
» Volume depletion- maintain good fluid intake» Renal dysfunction- adjust dose» Urinary alkalinization (treatment)
![Page 47: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/47.jpg)
Back to the case…
![Page 48: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/48.jpg)
What are NJ’s drug therapy problems associated with AKI?
• NJ’s acute renal failure may be secondary to drug-induced nephrotoxicity and requires reassessment of drug therapy.
• NJ requires assessment of drug therapy to optimize hemodynamics and other strategies to prevent further renal injury and promote resolution of AKI.
![Page 49: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/49.jpg)
What are the General Goals of Therapy for AKI?
1. Survive the insult2. Prevent further damage/insult3. Prevent/treat complications4. Regain life-sustaining renal function5. Minimize adverse effects of drug therapy
![Page 50: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/50.jpg)
What are your specific goals of therapy?
• Hemodynamics optimization– Maintain MAP > 60– Establish and maintain euvolemia
• Appropriate antibiotic and antifungal therapy to treat sepsis (treating the underlying cause)
• Discontinue nephrotoxic agents• Avoid further insults• Electrolyte management• Allow renal function to recover
![Page 51: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/51.jpg)
Principles of Therapy
• Prevention of AKI• Optimization of hemodynamic status– Appropriate fluid therapy– Vasopressors/ inotropes
• Treatment of underlying medical condition: sepsis, hemorrhage
• Discontinuation nephrotoxic medications• Adjust medication dosing
![Page 52: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/52.jpg)
What is the pharmacotherapeutic plan?
• Optimize hemodynamics and maintain renal perfusion– Reassess fluid status
• If fluid overloaded, minimize fluid intake through IVs (Concentrate meds, meds in NS)
• Cautious trial of furosemide once hemodynamically stable and off norepinephrine
• Discontinue use of antibiotics NJ has been recently exposed to
• Discontinue/avoid nephrotoxic agents• Adjust medication doses for decreased GFR• If on opioids, consider switching morphine to
hydromorphone or fentanyl
![Page 53: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/53.jpg)
A Look Back At How NJ Was TreatedDo You Agree?
• Transfused x 1 unit PRBC• Abx– Ceftriaxone 1 g IV q24h (~25 mg/kg/d) (Mar 20- 25)– Prednisolone 10 mg po bid x 1 wk (~0.5 mg/kg/d)
(Mar 20-26) – Ampicillin 500 mg IV q6h (~50 mg/kg/d) (Mar 25-
• Paracetamol 500 mg po tds x 3d) • Folic acid 5 mg po daily x 1 month• Multivitamins 10 mg po daily x 1 wk
![Page 54: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/54.jpg)
Case (update)
• Mar 26: able to pass urine, volumes increased to 1L/day, non bloody
• Mar 30: Normal urine output, afebrile, mild pallor, no oedema
• No vomitting, no fever, no swelling • Discharged Mar 30, 2013; for follow up in
renal clinic in 7 days
![Page 55: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/55.jpg)
Drug-Inducted NephrotoxicityKey Points
• Pretreatment hydration can reduce nephrotoxic potential of many drugs
• Renal injury can present as acute renal failure, nephrotic syndrome, renal tubular dysfunction, or chronic renal failure
• Early diagnosis is key
• Be aware of nephrotoxic potential of medications
• Be vigilant to exclude drugs as possible causes of renal disease
• Manage renal failure (replace fluid volume, adjust drug doses, steroid trials in AIN, avoid repeat exposures)
![Page 56: Drug induced nephritis](https://reader035.vdocument.in/reader035/viewer/2022062405/556b1801d8b42adb338b4799/html5/thumbnails/56.jpg)